Improved Myocardial Function With Coronary Sinus Reducer in a Patient With Refractory Angina and Heart Failure With Reduced Ejection Fraction

The Canadian Journal of Cardiology
Guglielmo GalloneFrancesco Giannini

Abstract

The coronary sinus Reducer represents a novel therapeutic option with established safety and clinical benefit in the treatment of patients with refractory angina, possibly achieved by enhancing perfusion of myocardial ischemic territories. We report the first case providing insight on how improved perfusion might translate into improved myocardial function as assessed by cardiac magnetic resonance strain imaging, thus suggesting a physiological rationale to test coronary sinus Reducer in the setting of ischemic cardiomyopathy with reduced ejection fraction and adverse remodelling.

Citations

Aug 23, 2020·Biomedicines·Kudrat Rakhimov, Tommaso Gori

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiomyopathy

Cardiomyopathy is a disease of the heart muscle, that can lead to muscular or electrical dysfunction of the heart. It is often an irreversible disease that is associated with a poor prognosis. There are different causes and classifications of cardiomyopathies. Here are the latest discoveries pertaining to this disease.

Related Papers

International Journal of Cardiology
Fan OuyangYuan Guo
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation
Yoav Paz, Amihay Shinfeld
International Journal of Cardiology
Francesco GianniniStefan Verheye
© 2021 Meta ULC. All rights reserved